icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Canada Goes Fully Legal

By Yona Torres Editor New Frontier Data All eyes are on Canada as the country takes its first few steps into a fully legal cannabis landscape. As such, Canada is taking a measured pace in its rollout of legal adult-use cannabis. The country is currently limiting its product offerings and will not permit edibles. “We […]
Read more

New York State Holds ‘Listening Sessions’ on Cannabis Legalization

By Noah Potter, Of Counsel to Hoban Law Group Last month, New York State Governor Andrew Cuomo’s office announced a series of 15 listening sessions about cannabis legalization (including one in Manhattan last week) to hear public comment through October. Cuomo’s new approach contrasts with the process that resulted in enactment of the Compassionate Care […]
Read more

Identifying the Relative Value of a Cultivator License, By State

  By Beau Whitney, Senior Economist for New Frontier Data With investors seeking data about how to ascertain the value of a license, or at least identify and contrast opportunities, New Frontier Data recently compared the respective Total Addressable Market (TAM) in each of six states to the number of licenses they have respectively proposed or […]
Read more

How to Avoid Investor Disconnect

By Jeffrey E. Finkle I recently was asked to judge a pitching competition for CannInvest NJ. The format was familiar, each participant was given eight minutes to pitch their business idea to a panel of judges and an audience of on-lookers. The judges gave feedback and voted to determine a winner. Most of the presentations […]
Read more

Canadian Cannabis Investor Never Bargained for Surprise Lifetime U.S. Ban

By J.J. McCoy, Senior Managing Editor for New Frontier Data   Just as investors on both sides of the U.S.-Canadian border look to involve themselves in a nascent legal cannabis industry heating up throughout North America, the U.S. Customs and Border Protection has cast a chill by threatening Canadian investors with lifetime visitation bans to their […]
Read more

Canadian Cannabis Investor Never Bargained for Surprise Lifetime U.S. Ban

By J.J. McCoy, Senior Managing Editor for New Frontier Data Just as investors on both sides of the U.S.-Canadian border look to involve themselves in a nascent legal cannabis industry heating up throughout North America, the U.S. Customs and Border Protection has cast a chill by threatening Canadian investors with lifetime visitation bans to their southern […]
Read more

Mass Overdoses from Synthetic Marijuana Remind Need for Public Education

By New Frontier Data Wednesday’s reported mass overdose on synthetic cannabinoids by nearly 80 people near Yale University – on the heels of 300 reported cases in a two-week span in Washington, D.C – serves as stark reminder to public health officials and the legal cannabis industry at large the need for better awareness and […]
Read more

Trying to Catch the Crest of the Cannabis Wave This Summer

By J.J. McCoy, Senior Managing Editor for New Frontier Data Tracking trends in the burgeoning U.S. cannabis industry can be a dizzyingly ambitious activity. There are now 30 states plus the District of Columbia (D.C.) which have legalized cannabis for medical use, and 9 states plus D.C. which have legalized cannabis for adult-use. Another handful of […]
Read more

U.S. Total CBD Market By Sector (in Millions)

  The FDA last week approved UK-based GW Pharmaceuticals’ Epidiolex, a “pure plant-derived CBD” extract shown to drastically reduce seizures in children with epileptic syndromes. Marking the FDA’s first-ever approval of a cannabis-derived pharmaceutical product, the DEA has 90 days (until September 23) to schedule Epidiolex, a landmark decision being carefully scrutinized by the industry at [...]
Read more

Additional Revenues from Potential State Legalization

  More than a dozen states are expected pass new cannabis legalization measures before 2025. Of them, four are expected to open medical markets, while nine may embrace adult use. The new markets may add another $21.4 billion (a 22% increase) in total revenue to the U.S. legal market between 2021 and 2025. The revenue increase […]
Read more